Senior insider sale
ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$48.9K
28.56K shares
What this filing means
GALLAGHER CAM plans to sell 28.56K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $48.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2025ACC: 0001725160-25-000018
Director
Since Apr 2020
28.56K
Shares to sell
$48.9K
Approx. market value
28.56K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
2/1/2025
28.56KTotal acquired28.56K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2025 | Restricted Stock Unit Release NA | 28.56K | — |
| Total | 28.56K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
28.56K
Market value
$48.9K
2/3/2025
Total
Units
28.56K
Value
$48.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/3/2025 | 28.56K | $48.9K | NASDAQ | Planned |
| Total | 28.56K | $48.9K | ||